- DEAN OF INTERNATIONAL CLINICAL AFFILIATIONS
- PROFESSOR Medicine, Cardiology
American Board of Internal Medicine
- Acute Coronary Syndrome
- Cardiac Catherization
- Heart Attack/Acute Coronary Syndrome
- Valvular Heart Disease
MD, Medical College Jaipur
Residency, Internal Medicine
New York University Downtown Hosp.
City Hospital Center at Elmhurst
Dr. Samin K. Sharma performs over 1500 complex coronary interventions annually (the highest in the country) while achieving an extremely low complication rate. According to New York State Department of Health reports (1994-2002, 2006-2008), he has the highest angioplasty success rate and lowest mortality <0.2% for an interventional cardiologist in NY State since1994, receiving prestigious **star designation (significantly lower than expected mortality). Under Dr. Sharma’s leadership, The Mount Sinai Hospital Cardiac Cath Lab has become one of the best and busiest centers in New York, providing state-of-the-art cardiac and interventional care for all types of simple and complex heart patients. In addition to coronary interventions, Dr. Sharma specializes in the non-surgical treatment of mitral and aortic stenosis and transcatheter aortic valve replacement (TAVR).
Dr. Sharma serves on the Cardiac Advisory Board of New York State since 2004 for coronary interventions that advises the Health Department and the Governor on issues of health policies and supervision, safety, and appropriateness of heart care by various hospitals in New York. Dr. Sharma received the Governor’s Award of Excellence (2006), for his outstanding contribution to Medicine.
Dr. Sharma also has passion for teaching and training fellows who enjoy learning from his expertise, so much so they awarded him the Simon Dack Best Teacher in the Division of Cardiology in 2000 and Cardiology Fellows Appreciation Award in 2009. Dr. Sharma travels to India 4-6 times a year to teach the art of angioplasty to Indian cardiologists. He is the vice-president of the Rajasthan Development Foundation and donated medical equipment worth one lakh Rs/month for six years (2001-2007) to the Chief Minister relief fund to help Rajasthan’s people in need. In addition to various academic awards, Dr. Sharma also received numerous awards from nonacademic societies such as the “Rajasthan Gaurav,” given by the Sanskriti organization of Rajasthan and the Rajive Gandhi Memorial Award. Now he has developed a state of the art Heart Hospital (Eternal Heart Care Center EHCC) in his native place Jaipur, India, which provides excellent care to all kinds of patients, including underprivileged and those living below the poverty level.
Under the directorship of Dr. Sharma, the Live Symposium of Complex Coronary & Vascular Cases (www.cccsympsoium.org) started in 1998 and has had overwhelming attendance every year (attended by >1000 delegates). Major emphasis of the live course has been the technical aspects of safely performing complex coronary interventions. In July 2009, Dr. Sharma launched a monthly live web series, (www.ccclivecases.org), a revolutionary teaching tool in interventional cardiology globally. This live program focuses on helping the audience understand the complexity of interventional disease management. Dr. Sharma partnered with Medscape/TheHeart.org in September 2010 and then with ACC/CardioSource.org in July 2012, to enhance this live webcast globally and widen his audience and is now attended by >2000 viewers per webcast.
A regular fixture on international, national, and local TV stations, newspapers and magazines, Dr. Sharma has been the focus of news stories for media outlets like: The Today Show, CBS News, NBC News, Fox News, PIX11, The New York Times, The Wall Street Journal, New York Magazine, Reuters, Businessweek, Cardiology Today, India Abroad, India Today, Barron’s, Forbes, Newsweek, The Washington Post, Crain’s New York Business, NY Daily News, Newsday, New York Post, and EveryDayHealth.com.
Dr. Sharma has been the recipient of numerous awards for excellence from medical societies and the community, to name a few recent ones: 2011 Ellis Island Medal of Honor, 2011 American Heart Association Achievement in Cardiovascular Science & Medicine Award, 2011 American Association of Physicians of Indian Origin (AAPI), 2010 Association of Indians in America (AIA) for Excellence in Medicine, 2010 Honored by AAPI forum of Tri-State Area for Academic Excellence, 2005-2007 and 2012-2014 Best Doctors, 2008-2014 Super Doctors, 2007 Jacobi Medallion Award at The Mount Sinai Hospital, 2007 Physician of the Year at The Mount Sinai Hospital.
Dr. Sharma received his medical degree from S.M.S. Medical College in 1978, Jaipur, India, where he was ranked the number one student in his medical school and State University receiving eight gold medals and five honors. In 1983, he came to New York to undergo residency in Internal Medicine at the NY Infirmary-Beekman Downtown Hospital (1983-1986), fellowship in Cardiology in Elmhurst Hospital (1986-1988), and interventional training at The Mount Sinai Hospital (1988-1990). He was then appointed as an attending at The Mount Sinai Hospital in 1990 where he is currently the Director of Interventional Cardiology (since 1996), Director of Clinical Cardiology (since 2011), Dean of International Clinical Affiliations (since 2011), President of Mount Sinai Heart Network (since 2011) and is the Zena and Michael A. Wiener Professor of Medicine, Cardiology (since 2002). He has authored over 150 articles, 350 abstracts, 14 book chapters and three books to his credit.
2012 - 2014
America's Top Doctors
2008 - 2014
Jacobi Medallion Award
Mount Sinai Physician of the Year Award
Governor's Award of Excellence
2005-2007 - 2012-2014
New York Magazine Best Doctors
Zena and Michael A. Wiener Professor of Medicine
Jaipur by Rajasthan Government of India
Simon Dack Award for Best Teacher at Cardiovascular Institute
The Mount Sinai Hospital
1996 - 2000
Center of Excellence Award for Rotational Coronary Atherectomy
1995 - 2003
Lowest complication rate of angioplasty
DOH New York State statistics
Best medical and chief resident
NY Infirmary-Beekman Downtown Hospital
Chen V, Sharma S. Coronary interventional devices: Balloon, atherectomy, thrombectomy and distal protection devices. Cardiol Clin 2006; 24(2): 201-215.
Wu C, Hannan E, Walford G, Ambrose J, Jones R, King S, Clark T, Katz S, Sharma S, Holmes D. A risk score to predict in-hospital mortality for percutaneous coronary interventions. J Am Coll Cardiol 2006; 47: 654-660.
Hannan E, Racz M, Holmes D, King S, Jones R, Ambrose J, Sharma S, Katz S, Clark L, Walford G. Impact of completeness of percutaneous coronary intervention revascularization on long-term outcomes in the stent era. Circulation 2006; 113: 2406-2412.
Sharma S, Kini A, Mares A, Tamburino F. Improved outcome with AngioJet thrombectomy during primary stenting in acute myocardial infarction patients with high-grade thrombus. J Invasive Cardiol 2006; 18: 8C-11C.
Sharma S. Simultaneous kissing drug-eluting stent technique for percutaneous treatment of bifurcation lesions in large. Cathet Cardiovasc Interv 2005; 65: 10-16.
Agarwal A, Kini A, Attanti S, Sharma S, Ashtiani R, Steinheimer A, Moreno P, Lee P. Results of repeat balloon valvuloplasty for treatment of aortic stenosis in patients aged 59 to 104 years. Am J Cardiol 2005; 95: 43-47.
Lee P, Kini A, Sharma S, Fisher E, Ashan C. Anemia as a risk factor for Percutaneous Coronary Intervention. J Am Coll Cardiol 2004; 44: 541.
Erdel C, Sharma S, Marmur J, Kini A. The current status of rotational atherectomy. Cathet Cardiovasc Interv 2004; 62: 485.
Kim M, Sharma S, Kini A. Therapeutic options in patients with refractory angina. J Am Coll Cardiol 2002; 39: 923.
Kini A, Sharma S, Mitre C, Reich D. A risk stratification scheme for selection of a glycoprotein IIb/IIIa inhibitor during percutaneous coronary intervention based on clinical and angiographic criteria. Am J Cardiol 2001; 88: 1287.
- XIENCE V Everolimus Eluting Coronary Stent System (EECSS) USA Post-Approval Study
- JOSTENT Coronary Stent Graft
- COSTAR II Trial
- A Prospective, Single Blind, Randomized Controlled Study to Evaluate the Safety And Effectiveness of the Tryton Side Branch Stent™ used in Conjunction with a Drug-Eluting Stent Compared to Side Branch Balloon Angioplasty in Conjunction with a Drug-Eluting Stent in the Treatment of de novo Bifurcation Lesions Involving the Main Branch and Side Branch within the Native Coronary Circulation (TRYTON side-branch stent TRIAL)
- A Prospective, multi-center, randomized controlled trial of the IMPELLA RECOVER LP 2.5 System versus Intra Aortic Balloon Pump (IABP) in Patients Undergoing Non Emergent High Risk PCI [Protect II]
- A Prospective, Two-Arm, Open-Label, Multi-Center Registry using XIENCE PRIME EECSS and XIENCE PRIME LL EECSS (SPIRIT-PRIME)
- CObalt chromium STent with Antiproliferation for Restenosis II Trial
- Future Revascularization Evaluation in Patients with Diabetes Mellitus:Optimal Management of Multivessel Disease (FREEDOM Trial)
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Sharma during 2013 and/or 2014. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Scientific Advisory Board:
- Cardiovascular Systems, Inc. (CSI)
Industry-Sponsored Lectures: MSSM faculty occasionally give lectures at events sponsored by industry, but only if the events are free of any marketing purpose.
- Abbott Laboratories; AngioScore, Inc.; Boston Scientific Corporation; Cardiovascular Systems, Inc. (CSI); Daiichi-Sankyo Co., Ltd. / Eli Lilly and Company Partnership; Medtronic, Inc.; The Medicines Company
Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)
- Eternal Heart Care Centre and Research Institute Private Limited (EHCRI)
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.
Klingenstein Clinical Center Floor 6th Floor Room 6N-665
1450 Madison Avenue
New York, NY 10029
1190 Fifth Avenue - 1 South
New York, NY 10029
- Wednesday 2:00pm - 6:30pm
- Indian (Hindi)
- Aetna U.S. Healthcare
- Beech Street
- Best Doctor
- CarePlus, LLC
- CenterCare, Inc.
- Devon Health Services
- Empire Blue Cross/Blue Shield
- Empire Health Choice, Inc.
- Fidelis Care NY
- First Health
- Group Health Insurance, Inc.
- Health Insurance Plan (HIP)
- HealthPlus, Inc.
- Horizon Healthcare
- Island Group
- Local 1199
- Medicaid New Jersey
- MetroPlus Health Plan
- MultiPlan, Inc.
- Neighborhood Health Providers, LLC
- Oxford Health Plans
- Private Healthcare Systems (PHCS)
- Travel Care Services
- United Health Care Empire Plan
- United Healthcare
- WellCare of New York, Inc.
- Master Card
- American Express
- Personal Check